Skip to content
House Democrats are planning a new $2.4 trillion stimulus packages that will include unemployment aid. Yahoo Finance's Jessica Smith shares the details....
After an initial rejection in 2019 and a string of delays following a refiling of the regulatory application, Eton Pharmaceuticals Inc's (NASDAQ: ETON) out-licensed allergic conjunctivitis ophthalmic solution is finally ready to see the light of the day.FDA Hurdle Cleared: The FDA gave its nod to an EM-100 ophthalmic solution, 0.035%, antihistamine drop, to be used as the first over-the-counter, preservative-free formulation eye drop to temporarily relieve itchy eyes dye to pollen, ragweed, grass, animal hair and dander in adults and children 3 and older, Eton and Bausch Health Companies Inc (NYSE: BHC) said.Eton out-licensed EM-100 to Bausch Health in February 2019.Itchy eyes are one of the symptoms that affect approximately 80% of people with allergies, the companies said.The preservatives commonly used in eye drops can cause allergic reactions in some people that can lead to redness, irritation, itching or tearing. What's Next: Bausch expects to make EM-100, or Alaway Preservative...
For an active investor using the top-down approach or bottom-up approach for new stocks to buy, there is no dearth of opportunities. Initial public offering is one major source of identifying value creators and holding them for the long term. This statement is backed by the fact that the S&P U.S. IPO & Spinoff Index has delivered annualized returns of 13.33% in the last 10 years.I believe that careful stock selection from among the IPOs or special purpose acquisition companies can help investors outperform the index. This column will look at four new stocks to buy that have the potential to be value creators in the coming years.I am discussing two IPOs from the year besides two SPACs. As the article from Harvard Law School Forum indicates, the total number of SPAC IPOs have been on a steady increase. And there are some exciting names to consider.InvestorPlace - Stock Market News,...
(Bloomberg Opinion) -- It feels a bit soon to declare jackpot. The market is betting on a heated auction after U.K. bookmaker William Hill Plc confirmed a Bloomberg News report of bid interest from buyout shop Apollo Global Management Inc., adding that its U.S. partner, Caesars Entertainment Inc., is circling too.But there must be some doubt over whether a deal really can be done much above the levels investors are hoping for.William Hill stock has settled around 290 pence, about a 70% premium to the company’s share price the day before Apollo submitted a written offer on Aug. 27. That’s around 50% above the share price just before the pandemic gripped markets in late February, and one-third above William Hill’s closing price on Thursday. It’s as if a deal has already been done and investors are simply waiting for it to close.The company isn’t revealing the price, but what’s on the table was evidently good enough for talks....
The U.S. is inching closer to hitting 7 million coronavirus cases as Midwest states like Wisconsin, Montana and South Dakota see an uptick. This comes as big pharmaceutical companies race to find a vaccine. Yahoo Finance's Anjalee Khemlani joins The First Trade with Alexis Christoforous and Brian Sozzi to discuss that and what pharmaceutical companies are close to reaching final stages of coronavirus vaccine trials....
Bill Thomas became the CEO of EOG Resources, Inc. (NYSE:EOG) in 2013, and we think it's a good time to look at the......
